» Articles » PMID: 28507844

An Innovative Risk-Reducing Approach to Postmastectomy Radiation Delivery After Autologous Breast Reconstruction

Overview
Specialty General Surgery
Date 2017 May 17
PMID 28507844
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Postmastectomy radiation therapy (PMRT) has known deleterious side effects in immediate autologous breast reconstruction. However, plastic surgeons are rarely involved in PMRT planning. Our institution has adopted a custom bolus approach for all patients receiving PMRT. This offers uniform distribution of standard radiation doses, thereby minimizing radiation-induced changes while maintaining oncologic safety. We present our 8-year experience with the custom bolus approach for PMRT delivery in immediate autologous breast reconstruction.

Methods: All immediate autologous breast reconstruction patients requiring PMRT after 2006 were treated with the custom bolus approach. Retrospective chart review was performed to compare the postirradiation complications, reconstruction outcomes, and oncologic outcomes of these patients with those of previous patients at our institution who underwent standard bolus, and to historical controls from peer-reviewed literature.

Results: Over the past 10 years, of the 29 patients who received PMRT, 10 were treated with custom bolus. Custom bolus resulted in fewer radiation-induced skin changes and less skin tethering/fibrosis than standard bolus (0% vs 10% and 20% vs 35%, respectively), and less volume loss and contour deformities compared with historical controls (10% vs 22.8% and 10% vs 30.7%, respectively).

Conclusions: Custom bolus PMRT minimizes radiation delivery to the internal mammary vessels, anastomoses, and skin; uniformly doses the surgical incision; and provides the necessary radiation dose to prevent recurrence. Because custom bolus PMRT may reduce the deleterious effects of radiation on reconstructive outcomes while maintaining safe oncologic results, we encourage all plastic surgeons to collaborate with radiation oncologists to consider this technique.

Citing Articles

Long-term outcomes of immediate autologous breast reconstruction after definite adjuvant therapy in intermediate and locally advanced breast cancer.

Yoon W, Rim C, Yang D, Lee J, Son G, Chang Y Ann Transl Med. 2020; 7(23):743.

PMID: 32042759 PMC: 6990026. DOI: 10.21037/atm.2019.11.129.

References
1.
Su Y, Li S, Chen Y, Chen H, Tang Y, Huang C . Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis. Radiol Oncol. 2014; 48(3):314-22. PMC: 4110089. DOI: 10.2478/raon-2013-0085. View

2.
Sitathanee C, Puataweepong P, Swangsilpa T, Narkwong L, Kongdan Y, Suvikapakornkul R . Acute effects of postmastectomy radiotherapy after immediate TRAM flap reconstruction in breast cancer patients. J Med Assoc Thai. 2006; 88(12):1861-6. View

3.
Stewart F, Hoving S, Russell N . Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res. 2010; 174(6):865-9. DOI: 10.1667/RR1862.1. View

4.
Thomas K, Rahimi A, Spangler A, Anderson J, Garwood D . Radiation practice patterns among United States radiation oncologists for postmastectomy breast reconstruction and oncoplastic breast reduction. Pract Radiat Oncol. 2014; 4(6):466-71. DOI: 10.1016/j.prro.2014.04.002. View

5.
Selber J, Kurichi J, Vega S, Sonnad S, Serletti J . Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg. 2006; 56(5):492-7. DOI: 10.1097/01.sap.0000210180.72721.4a. View